Glaxosmithkline, LLC Contracts in North Carolina
Federal contract operations by Glaxosmithkline, LLC performed in North Carolina (NC)
Overview
Total Contract Value: $5,062,801,775
Contract Count: 20
Average Contract Size: $253.1M
Sole Source Rate: 0%
Small Business Rate: 0%
Awarding Agencies
- Department of Health and Human Services — $2.8B (17 contracts)
- Department of Defense — $2.2B (3 contracts)
Spending by Sector
- Other: $5.1B (20 contracts)
Contracts
- :COVID-19: SOTROVIMAB MONOCLONAL ANDTIBODIES — $1.6B
- IGF::OT::IGF VACINES FOR CHILDREN — $682.2M
- VACCINE FOR CHILDREN (VFC) 2014 — $602.0M
- VACCCINE FOR CHILDREN 2012 — $554.8M
- VACCINE FOR CHILDREN 2013 — $526.1M
- GLAXOSMITHKLINE ADJUVANT AS03 — $335.6M
- :COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB — $279.9M
- TASK ORDER 0003 — $66.4M
- IGF::OT::IGF 2016 PED FLU — $56.0M
- PEDIATRIC FLU VACCINE — $51.0M
- 2015-2016 PEDIATRIC FLU VACCINES — $50.7M
- MODIFICATION 00001: CLARIFICATION OF SHELF-LIFE DATING — $50.0M
- PEDIATRIC FLU VACCINES 2014-2015 — $49.6M
- FY18 PRODUCT PROCUREMENT — $40.6M
- TASK ORDER 0002 — $33.0M
- THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD. — $22.9M
- 2012 ADULT VACCINES — $20.6M
- THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE UNDER CONTRACT 75A50122D00002. — $18.2M
- AS03B-H7N9 VACCINE CLINICAL STUDY — $18.2M
- THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D000002 DURING BASE PERIOD YR. 3. PERIOD OF PERFORMANCE: FEBRUARY — $7.8M
Frequently Asked Questions
How many contracts does Glaxosmithkline, LLC have in North Carolina?
Glaxosmithkline, LLC has 20 contracts performed in North Carolina worth a combined $5.1B.
What is the average contract size for Glaxosmithkline, LLC in North Carolina?
The average contract size is $253.1M.